STI1 promotes glioma proliferation through MAPK and PI3K pathways

GLIA

Volumn 55, Issue 16, 2007, Pages 1690-1698

  Erlich, Rafael B ^a,d   Kahn, Suzana A ^a   Lima, Flávia R S ^b   Muras, Angelita G ^b,c   Martins, Rodrigo A P ^a,e   Linden, Rafael ^a   Chiarini, Luciana B ^a   Martins, Vilma R ^b,f   Neto, Vivaldo Moura ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Cellular prion protein; Glioma; Proliferation; STI1

Indexed keywords

HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS INDUCIBLE PROTEIN 1; THYMIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

EID: 35349020550     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20579     Document Type: Article

References (46)

1. Aguzzi A, Polymenidou M. 2004. Mammalian prion biology: One century of evolving concepts. Cell 116:313-327.
2. Aguzzi A, Weissmann C. 1997. Prion research: The next frontiers. Nature 389:795-798.
3. Americo TA, Chiarini LB, Linden R. 2007. Signaling induced by hop/STI-1 depends on endocytosis. Biochem Biophys Res Commun 358:620-625.
4. C. Biochem Biophys Res Commun, in press.
5. Boquet D, Dery O, Frobert Y, Grassi J, Couraud JY. 1995. Is hydropathic complementarity involved in antigen-antibody binding? Mol Immunol 32:303-308.
6. Bottazzi ME, Zhu X, Bohmer RM, Assoian RK. 1999. Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol 146:1255-1264.
7. Brentani RR. 1988. Biological implications of complementary hydropathy of amino acids. J Theor Biol 135:495-499.
8. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
9. Caughey B, Race RE, Chesebro B. 1988. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J Gen Virol 69 (Pt 3):711-716.
10. Chen S, Smith DF. 1998. Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J Biol Chem 273:35194-35200.
11. Chen TC, Hinton DR, Zidovetzki R, Hofman FM. 1998. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest 78:165-174.
12. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. 2002. Cellular prion protein transduces neuroprotective signals. EMBO J 21:3317-3326.
13. Comincini S, Facoetti A, Del Vecchio I, Peoc'h K, Laplanche JL, Magrassi L, Ceroni M, Ferretti L, Nano R. 2004. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: A new molecular marker potentially involved in tumor progression. Anticancer Res 24(3a):1507-1517.
14. Corradetti MN, Guan KL. 2006. Upstream of the mammalian target of rapamycin: Do all roads pass through mTOR? Oncogene 25:6347-6360.
15. Eustace BK, Jay DG. 2004. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 3:1098-1100.
16. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C, Lain B, Torella C, Henning SW, Beste G, Scroggins BT, Neckers L, Ilaq LL, Jay DG. 2004. Functional proteomic screens reveal an essential extracellular role for hsp90 α in cancer cell invasiveness. Nat Cell Biol 6:507-514.
17. Flavia RSM, Camila PA, Angelita GM, Regina N, Ricardo RB, Vilma RM. 2007. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J. Neurochem published online 9-Aug-2007 DOI:10.1111/J. 1471-4159.2007.0494.
18. Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD, Vojtek AB. 2000. Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275:27354-27359.
19. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
20. Hetz C, Maundrell K, Soto C. 2003. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 9:237-243.
21. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. 2003. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425:407-410.
22. Kleihues P, Cavanee WK. 2000. World Health Organization classification of tumors of the nervous system. Lyon: IARC/WHO.
23. Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, Prado MA. 2001. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 79:79-87.
24. Lee WC, Choi CH, Cha SH, Oh HL, Kim YK. 2005. Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30:263-270.
25. Liang J, Pan Y, Zhang D, Guo C, Shi Y, Wang J, Chen Y, Wang X, Liu J, Guo X, Chen Z, Qiao T, Fan D. 2007. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 21:2247-2256.
26. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, Brentani RR, Linden R, Martins VR. 2005. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 25:11330-11339.
27. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. 2001. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15:1311-1333.
28. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
29. Martins VR, Graner E, Garcia-Abreu J, de Souza SJ, Mercadante AF, Veiga SS, Zanata SM, Neto VM, Brentani RR. 1997. Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 3:1376-1382.
30. Martins VR, Mercadante AF, Cabral AL, Freitas AR, Castro RM. 2001. Insights into the physiological function of cellular prion protein. Braz J Med Biol Res 34:585-595.
31. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M. 2002. Regulation of Raf-Akt Cross-talk. J Biol Chem 277:31099-31106.
32. Murphy LO, Blenis J. 2006. Mapk signal specificity: the right place at the right time. Trends Biochem Sci 31(5):268-275.
33. Nickel W. 2005. Unconventional secretory routes: direct protein export across the plasma membrane of Mammalian cells. Traffic 6:607-614.
34. Nicolet CM, Craig EA. 1989. Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae. Mol Cell Biol 9:3638-46.
35. Odunuga OO, Longshaw VM, Blatch GL. 2004. Hop: More than an Hsp70/Hsp90 adaptor protein. Bioessays 26:1058-1068.
36. Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu N, Zhang G, Jin H, Gao J, Xie H, Wang J, Liu Z, Fan D. 2006. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 20:1886-1888.
37. Prusiner SB. 1998. Prions. Proc Natl Acad Sci USA 95:13363-13383.
38. Pumiglia KM, Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448-452.
39. Samaia HB, Brentani RR. 1998. Can loss-of-function prion-related diseases exist? Mol Psychiatry 3:196-197.
40. Sebolt-Leopold JS, Herrera R. 2004. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937-947.
41. Sewing A, Wiseman B, Lloyd AC, Land H. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17:5588-5597.
42. Sharrocks AD. 2006. Cell cycle: Sustained ERK signalling represses the inhibitors. Curr Biol 16:R540-R542.
43. Shingu T, Yamada K, Hara N, Moritake K, Osago H, Terashima M, Uemura T, Yamasaki T, Tsuchiya M. 2003. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells. Cancer Res 63:4044-4047.
44. Song Y, Masison DC. 2005. Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1 (Hop1). J Biol Chem 280:34178-34185.
45. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR. 2002. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21:3307-3316.
46. Zimmermann S, Moelling K. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.